Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Hydromorphone PCIA After Orthopedic Surgery
ChiCTR2500113933Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine in acute postoperative pain (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Overall incidence of postoperative nausea and vomiting (PONV) within 48 hours after surgery. Started Dec 2025; status: recruiting.
02
Drugs
oliceridine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2500113933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113933.